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The prorenin receptor is involved  
in Wnt signaling
Cruciat et al., Science 2010; 327: 459–463; doi:10.1126/science.1179802
Wnts, of which 19 isoforms have been identified in humans, 
are secreted glycoproteins that, upon binding to their receptors 
(low-density lipoprotein receptor-related protein 6 and Frizzled), 
activate at least two groups of signaling pathways: the canonical 
Wnt/β-catenin pathway (which activates β-catenin-responsive 
target genes) and the β-catenin-independent pathways. There 
are, in addition, several secreted proteins known to regulate Wnt 
signaling, such as the Dickkopf family, secreted Frizzled-related 
proteins, and Wnt inhibitory factor-1. Yet the mechanism of Wnt 
signal transmission, notably how the receptors are activated, is still 
poorly understood. Aiming to identify new Wnt receptor regu-
lators, Cruciat et al. performed a genome-wide small interfering 
RNA (siRNA) screen and found that the prorenin receptor (PRR) is 
a component of the Wnt receptor complex. Specifically, they trans-
fected individual human embryonic kidney cells with siRNA pools 
targeting many human genes, stimulated the cells with Wnt3a, and 
analyzed for transcription of a Wnt-responsive luciferase reporter. 
Three independent siRNAs targeting PRR inhibited luciferase 
reporter activity stimulated by Wnt3a but not by β-catenin, attest-
ing to the specificity of the effect. To test whether PRR was required 
for Wnt signaling in vivo, they used Xenopus embryos and found 
that tadpoles that developed from embryos injected with PRR 
antisense morpholino oligonucleotides had multiple defects, and 
this phenotype was efficiently rescued by co-injection of human 
PRR mRNA (Figure). Xenopus embryos have no prorenin, and 
renin had no effect in the Wnt luciferase assays, suggesting that 
PRR likely functions in Wnt signaling independently of renin 
and prorenin. Indeed, a PRR fragment has been identified as the 
adenosine triphosphatase (ATPase), H+-transporting, lysosomal 
accessory protein 2 (ATP6AP2), which interacts with the vacuolar 
H+-ATPase (V-ATPase). This ATPase is involved in multiple proc-
esses, and its main mechanism is to pump protons and acidify vesi-
cles. The authors found that inhibition of V-ATPase both in vitro 
and in vivo prevented Wnt/β-catenin signaling and that V-ATPase 
activity was required for activation of the Wnt receptor. This study 
reveals an unsuspected role for PRR in Wnt/β-catenin signaling 
and raises intriguing questions on the role of PRR. It also sug-
gests that V-ATPase could be a therapeutic target to modulate Wnt 
signaling in diseases.
Juan Oliver
Hyperaldosteronism in circadian 
clock–deficient mice
Doi et al., Nat Med 2009; 16: 67–74; doi:10.1038/nm.2061
Analysis of the molecular mechanisms of circadian clocks has 
shown that circadian oscillations in mammals are regulated by 
a core of genes that form the primary negative-feedback loop of 
the clock mechanism. The Cryptochrome-1 and -2 (Cry1, Cry2) 
genes are among these genes. Cry-null mice lack a functional 
circadian clock and thus show arrhythmic behavior, physiology, 
and metabolism. In characterizing the endocrinological profile 
of Cry-deficient mice, Doi et al. found very high levels of plasma 
aldosterone. Unlike wild-type (WT) mice, which showed a mild 
circadian fluctuation in plasma aldosterone, Cry-null mice had 
abnormally high aldosterone throughout the day (Figure). The 
figure also shows that the elevated aldosterone in Cry-null mice 
was not due to an elevated plasma renin. The authors also found 
that the aldosterone production rate of the Cry-null adrenal gland 
was significantly higher than that of WT animals. To understand 
why, Doi et al. used microarrays to survey all known mouse ster-
oidogenic genes for their expression in the adrenal gland. Their 
analysis identified Hsd3b6, an isoform of the Hsd3b gene family, 
which encodes dehydrogenase-isomerases, enzymes that catalyze 
the conversion of ∆5-3β-hydroxysteroids into hormonally active 
∆4-3-ketosteroids, a reaction required for aldosterone biosynthe-
sis. Interestingly, they found that Hsd3b expression in WT adre-
nal glands, although low, was subject to circadian fluctuation. In 
situ analysis and immune-location showed that Hsd3b6 and its 
product were expressed almost exclusively in the zona glomeru-
losa, the site of aldosterone synthesis. The elevated Hsd3b6 led to 
increased 3β-hydroxysteroid dehydrogenase-isomerase (3β-HSD) 
PRR is required for Wnt/β-catenin signaling and antero-posterior neural 
patterning in Xenopus. Xenopus embryos injected with control (top) or 
PRR antisense morpholino oligonucleotides in the absence (middle) or 
presence of wild-type human PRR mRNA (bottom).
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(a) Twenty-four-hour plasma aldosterone in wild-type (WT) and Cry-null 
mice. (b) Plasma renin activity in WT and Cry-null mice at CT0 and CT12.  
CT0 and CT12, beginning of subjective day and night, respectively.
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enzymatic activity and, thus, enhanced aldosterone production. 
While the circadian variation in blood pressure characteristic of 
WT mice was completely lost in the Cry-null mice, there was no 
significant difference in their baseline blood pressures. However, 
when mice were fed a high-salt diet, blood pressure in WT mice 
was unaffected, but Cry-null mice became hypertensive. Thus, 
circadian clock-deficient Cry-null mice have hyperaldosteronism, 
as inactivation of Cry genes leads to chronically enhanced aldos-
terone production. Given the current interest in circadian vari-
ation of blood pressure in health and disease, this study opens 
intriguing avenues of research.
Juan Oliver
The role of the polyol pathway 
in acute kidney injury caused by 
hindlimb ischemia in mice
Yagihashi et al., J Pathol advance online publication, 11 December 2009, 
doi:10.1002/path.2671
The polyol pathway, a collateral glycolytic process previously con-
sidered to be active in high-glucose milieus, is a key component 
of myocardial ischemic injury. Inhibitors of the enzyme aldose 
reductase (AR) limit ischemic injury and improve functional 
recovery upon reperfusion.1 In their recent study, Yagihashi et 
al. demonstrated that inhibition of the polyol pathway by an AR 
inhibitor (ARI) is beneficial in acute kidney injury caused by hind-
limb ischemia. Mice 8 weeks of age, rendered hindlimb-ischemic 
for 3 hours by the clipping of major supporting arteries, revealed 
marked muscle necrosis, with accumulation of sorbitol and fruc-
tose in ischemic muscles and kidney cortex (Figure). Serum con-
centrations of blood urea nitrogen, creatinine phosphokinase, 
creatinine, tumor necrosis factor, and interleukin-6 were all 
elevated in these mice. Treatment with ARI effectively suppressed 
muscle necrosis and accompanying inflammatory reactions and 
prevented renal failure. Like ARI-treated mice, AR-deficient mice 
were protected from severe ischemic limb injury and renal failure, 
showing only modest muscle necrosis and significant suppression 
of serum markers of renal failure and inflammation.
Thus, these findings suggest that the polyol pathway is impli-
cated in acute kidney injury caused by ischemic limb injury and 
point to AR as a potential therapeutic target for this condition.
Marc De Broe
1Diabetes 1997; 46: 292–300.
Albuminuria and proteinuria 
consistently signal cardiovascular 
risk across multiple diseases
George et al., AIDS 2010; 24: 387–394; doi:10.1097/QAD.0b013e3283359253
Choi et al., Circulation 2010; 121: 651–658; doi:10.1161/
CIRCULATIONAHA.109.898585
In patients with diabetes mellitus, albuminuria predicts overt pro-
teinuria, and overt proteinuria predicts end-stage renal disease 
(ESRD). Both predict death and cardiovascular events. Similar 
links have been established among persons with HIV. HIV is 
an independent risk factor for albuminuria,1 albuminuria pre-
dicts overt proteinuria,2 and proteinuria is associated with both 
increased risk of ESRD and death.3,4 However, it has been unclear 
whether these associations are due to cardiovascular morbidity 
and mortality. In a case−control study, George et al. found that an 
estimated glomerular filtration rate (eGFR) of less than 60 ml/min 
was associated with almost 16-fold greater odds of a cardiovas-
cular event. Further, a 10-ml/min decrease in eGFR was associ-
ated with 20% increased odds of a cardiovascular event. Similarly, 
proteinuria was associated with an increased risk of cardiovascu-
lar events. Choi et al. examined the data set of patients receiving 
care for HIV disease through the Veterans Health Administra-
tion. Among almost 18,000 HIV-infected patients receiving care, 
the rates of cardiovascular disease were at least sixfold greater in 
the highest-risk patients, with an eGFR less than 30 ml/min and 
albuminuria, than in patients with an eGFR greater than 60 ml/
min and no albuminuria. 
These two articles underscore the clinical utility of screening 
for albuminuria and proteinuria in asymptomatic patients with 
HIV. Although proteinuria is not fully validated as an interme-
diate marker, the relationships between this parameter and out-
comes are quite similar to those between diabetes mellitus and 
outcomes. The paradigm of biannual screening for kidney disease 
for all diabetes mellitus patients may be the appropriate paradigm 
to consider for all patients with HIV. We need to establish the indi-
cated therapies that will successfully modulate the elevated risk in 
HIV-infected patients who screen positive for albuminuria.
Lynda Szczech
1AIDS 2007; 21: 1003–1009. 2HIV Med advance online publication, 4 January 2010, 
doi:10.1111/j.1468-1293.2009.00805.x. 3Clin Infect Dis 2004; 39: 1199–1206. 4Kidney 
Int 2002; 61: 195–202. 
Carbohydrate levels in kidney cortex and AR expression in renal tissues 
in experimental mice. (a) There was significant elevation of sorbitol and 
fructose in mice with hindlimb ischemia. Treatment with ARI significantly 
inhibited the change. There was no alteration in AR knockout (KO) 
mice after ischemia. (b) AR expression in renal cortex and medulla was 
comparable in experimental mice with or without hindlimb ischemia. 
There was no expression in AR-KO mice. AR, aldose reductase; ARI, AR 
inhibitor; I, ischemia; mAR, mouse AR; NS, not significant; WT, wild-type.
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